Assessment and Management of Chronic Dyspepsia in Eastern Uganda

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

May 31, 2019

Study Completion Date

June 30, 2020

Conditions
Helicobacter Pylori InfectionDyspepsia
Interventions
DRUG

Clarithromycin 500mg

500 mg per os twice daily for 14 consecutive days.

DRUG

Amoxicillin 1000 MG

1000 mg per os twice daily for 14 consecutive days.

DRUG

Omeprazole 40 MG

40 mg per os twice daily for 14 consecutive days.

DRUG

Omeprazole 20 MG Oral Tablet

20 mg per os daily for 1 month; only for patients with chronic dyspepsia and who are negative for Helicobacter pylori.

Trial Locations (1)

63110

Washington University in St. Louis School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT04525664 - Assessment and Management of Chronic Dyspepsia in Eastern Uganda | Biotech Hunter | Biotech Hunter